toko

Company Overview

Snapshot

Founded in February 2024 by Maya Goldberg and Yuval Pitluk, toko operates with 1–10 employees. The company has secured funding across two rounds from two investors. In December 2025, toko received a Seed round with Adama Ventures as a lead investor.

Business overview

toko is a Health Tech & Life Sciences company focused on radically scaling access to mental health care through an AI-guided, peer-to-peer therapy model. The company delivers evidence-based therapy without traditional therapists, pairing two peers with shared life experiences for joint therapeutic processes. These sessions are guided by an AI psychological agent that fosters emotional growth, teaches SEM skills, and delivers clinically proven interventions. This full-stack AI solution aims to reduce therapy costs by over 90% while maintaining high clinical efficacy, shortening wait times, expanding mental health system reach, and improving productivity and healthcare outcomes. Tailored for prevention, mild conditions, and rehabilitation, toko enables providers to deliver high-quality care at scale, primarily serving the United States market.

Strategic signal

In March 2025, news highlighted toko's role in leveraging artificial intelligence to revolutionize post-trauma treatment in Israel. This indicates a significant strategic focus on addressing critical mental health challenges with advanced technology, positioning the company as a key innovator in digital therapeutics and demonstrating its potential to impact large-scale public health initiatives.

Company Intelligence Q&A

What is toko's primary focus in mental health care?

toko focuses on providing AI-guided, peer-to-peer therapy for mental health, aiming to scale access to care without traditional therapists by pairing individuals with shared experiences for guided therapeutic processes.

When was toko founded and by whom?

toko was founded in February 2024 by Maya Goldberg, who serves as CEO & Co-Founder, and Yuval Pitluk, Co-founder & COO.

Which investors participated in toko's December 2025 funding round?

In December 2025, toko received Seed funding from Adama Ventures, which was a lead investor.

How does toko's AI solution impact therapy costs and accessibility?

toko's full-stack AI solution is designed to reduce therapy costs by over 90% while maintaining high clinical efficacy, thereby shortening wait times and expanding the reach of mental health systems.

What was a key development for toko in March 2025?

In March 2025, news reports highlighted toko's pioneering use of artificial intelligence to lead a revolution in post-trauma treatment within Israel.